Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Gentris Launches Pharmacogenomics Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

Gentris Launches Pharmacogenomics Services

Adds technology platforms to GLP lab

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Gentris Corp. has expanded its genomic biomarker services, adding multiple technology platforms to its 24,000-sq.-ft., CLIA-certified, GLP-compliant lab. Gentris has integrated the Affymetrix GCS3000, Sequenom MassArray, and LifeTech Ion Torrent technologies to identify polymorphisms involved in drug response and adverse drug events as well as determining somatic mutations in cancer. 
 
Affymetrix DMET Plus analysis allows drug developers to understand how variations in drug metabolism enzymes and drug transporters between patients affects adverse drug responses and treatment efficacy. Sequenom’s MassArray allows for customized design for multiplex panels of genes for clinical trials. Additionally, the LifeTech’s Ion Torrent Personal Genome Machine (PGM) for next generation sequencing allows for rapid sequencing of large areas of the genome, which can identify both common and rare variations to better predict the safety and efficacy of new drugs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics